- Home
- CRVO vs LOAN Comparison
CRVO vs LOAN Comparison
Compare CRVO & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- LOAN
- Stock Information
- Founded
- CRVO 2001
- LOAN 1989
- Country
- CRVO United States
- LOAN United States
- Employees
- CRVO N/A
- LOAN N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- LOAN Real Estate Investment Trusts
- Sector
- CRVO Health Care
- LOAN Real Estate
- Exchange
- CRVO Nasdaq
- LOAN Nasdaq
- Market Cap
- CRVO 67.4M
- LOAN 61.5M
- IPO Year
- CRVO N/A
- LOAN 1999
- Fundamental
- Price
- CRVO $10.12
- LOAN $5.38
- Analyst Decision
- CRVO Strong Buy
- LOAN
- Analyst Count
- CRVO 6
- LOAN 0
- Target Price
- CRVO $17.60
- LOAN N/A
- AVG Volume (30 Days)
- CRVO 820.1K
- LOAN 20.0K
- Earning Date
- CRVO 08-08-2025
- LOAN 07-22-2025
- Dividend Yield
- CRVO N/A
- LOAN 8.55%
- EPS Growth
- CRVO N/A
- LOAN N/A
- EPS
- CRVO N/A
- LOAN 0.48
- Revenue
- CRVO $7,776,968.00
- LOAN $7,300,469.00
- Revenue This Year
- CRVO N/A
- LOAN N/A
- Revenue Next Year
- CRVO N/A
- LOAN $4.47
- P/E Ratio
- CRVO N/A
- LOAN $11.21
- Revenue Growth
- CRVO N/A
- LOAN N/A
- 52 Week Low
- CRVO $1.80
- LOAN $4.74
- 52 Week High
- CRVO $20.63
- LOAN $6.05
- Technical
- Relative Strength Index (RSI)
- CRVO 65.00
- LOAN 46.25
- Support Level
- CRVO $9.11
- LOAN $5.27
- Resistance Level
- CRVO $9.96
- LOAN $5.55
- Average True Range (ATR)
- CRVO 0.79
- LOAN 0.13
- MACD
- CRVO 0.06
- LOAN -0.02
- Stochastic Oscillator
- CRVO 90.31
- LOAN 28.95
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.